Danaher Corporation DHR

Danaher Corporation is a publicly traded company listed on NYSE under the ticker DHR. Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABC

Danaher Corporation (DHR) is trading at $182.67, up 1.13% on the day. Prices on this page update through the trading session. This is not financial advice.

Wall Street analysts currently rate DHR a consensus "Strong Buy", with an average 12-month price target of $245.39 (+34.34% vs the current price). Ratings are opinions, not guarantees — always do your own research.

The next Danaher Corporation earnings date is around Apr 21, 2026. Earnings dates can move — check the company's investor relations page to confirm.

Danaher Corporation pays a dividend with a current yield of about 0.88% ($1.60 per share annually).